ALDOB stands for "Aldose Reductase Inhibitor," a type of medication that helps manage complications related to diabetes. It works by inhibiting the enzyme aldose reductase, which converts glucose into sorbitol. By blocking this process, ALDOB can help reduce the accumulation of sorbitol in cells, potentially preventing damage to nerves, eyes, and kidneys. ALDOB is often studied for its role in treating diabetic complications, such as diabetic neuropathy and retinopathy. It is important for patients with diabetes to manage their blood sugar levels effectively, and ALDOB may be part of a broader treatment plan that includes lifestyle changes and other medications.